Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 11/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 10/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6249193 | 1.00 | HSD17B1 (0.45) | HSD17B1SIGMAR1ALDH1A1HSD17B2CYP3A4 | |
| SCHEMBL19211205 | 0.79 | KMT2A (0.43) | ALDH1A1LMNAKMT2A | |
| Benzene SCHEMBL28335658 | 0.76 | TRPM8 (0.50) | HSD17B1SIGMAR1ALDH1A1HSD17B2LMNA | |
| SCHEMBL1029152 | 0.76 | TRPM8 (0.50) | HSD17B1SIGMAR1ALDH1A1HSD17B2LMNA | |
| SCHEMBL12550525 | 0.74 | ALDH1A1 (0.53) | HSD17B1SIGMAR1ALDH1A1HSD17B2CYP3A4 | |
| SCHEMBL15904475 | 0.72 | SIGMAR1 (0.42) | HSD17B1SIGMAR1ALDH1A1HSD17B2CYP3A4 | |
| SCHEMBL29674730 | 0.72 | TSPO (0.53) | HSD17B1SIGMAR1ALDH1A1HSD17B2LMNA | |
| SCHEMBL2090213 | 0.72 | HSD17B1 (0.49) | HSD17B1SIGMAR1ALDH1A1HSD17B2LMNA | |
| SCHEMBL5042970 | 0.72 | TSPO (0.53) | HSD17B1SIGMAR1ALDH1A1HSD17B2LMNA | |
| Toluene SCHEMBL28335771 | 0.72 | HSD17B1 (0.50) | HSD17B1SIGMAR1ALDH1A1HSD17B2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6962930-B1 | Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage | LOHOCLA RESEARCH CORPORATION (US) | 2005-11-08 | — | — | US | claimed |
| EP-1011676-B1 | QUINOLINE-UREA DERIVATIVES FOR THE TREATMENT OF WITHDRAWAL SYNDROME AND WITHDRAWAL-INDUCED BRAIN DAMAGE | LOHOCLA RES CORP (US) | 2005-08-31 | — | — | EP | claimed |
| EP-1011676-A4 | COMPOUNDS, COMPOSITIONS AND METHOD SUITABLE FOR AMELIORATION OF WITHDRAWAL SYNDROMES AND WITHDRAWAL-INDUCED BRAIN DAMAGE | LOHOCLA RES CORP (US) | 2004-08-11 | — | — | EP | claimed |
| EP-1011676-A1 | COMPOUNDS, COMPOSITIONS AND METHOD SUITABLE FOR AMELIORATION OF WITHDRAWAL SYNDROMES AND WITHDRAWAL-INDUCED BRAIN DAMAGE | Lohocla Research Corporation (US) | 2000-06-28 | — | — | EP | claimed |
| WO-1998055125-A1 | COMPOUNDS, COMPOSITIONS AND METHOD SUITABLE FOR AMELIORATION OF WITHDRAWAL SYNDROMES AND WITHDRAWAL-INDUCED BRAIN DAMAGE | LOHOCLA RESEARCH CORPORATION (US) | 1998-12-10 | — | — | WO | claimed |